**Core Concept**
The ROME scheme is a classification system used for functional gastrointestinal disorders (FGIDs), which are characterized by chronic or recurrent gastrointestinal symptoms without any identifiable structural or biochemical abnormalities. The ROME scheme provides a standardized framework for diagnosing and categorizing FGIDs, facilitating effective communication among healthcare providers and researchers.

**Why the Correct Answer is Right**
The ROME scheme was introduced in response to the need for a universally accepted classification system for functional gastrointestinal disorders. The first version of the ROME criteria was published in 1990, and subsequent revisions have been made to improve the diagnostic accuracy and clinical relevance of the scheme. The ROME classification system takes into account the symptom duration, frequency, and severity, as well as the presence of alarm features such as weight loss, bleeding, or difficulty swallowing.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the ROME scheme is not primarily focused on inflammatory bowel disease (IBD), which is a distinct category of gastrointestinal disorders.
**Option B:** This option is incorrect because the ROME scheme is not solely based on the Rome II criteria, which is a specific version of the classification system.
**Option C:** This option is incorrect because the ROME scheme is not primarily focused on the pathophysiology of gastrointestinal motility disorders.

**Clinical Pearl / High-Yield Fact**
The ROME classification system is essential for diagnosing and managing functional gastrointestinal disorders, which are common and often challenging to diagnose. A thorough understanding of the ROME scheme is crucial for postgraduate medical students, as it enables them to accurately diagnose and manage patients with FGIDs.

**Correct Answer: D.**